FDA panel backs Glaxo drug for rare sarcoma cancer
Tuesday, March 20, 2012 - 12:31
in Health & Medicine
WASHINGTON (AP) -- A panel of cancer experts overwhelmingly backed the approval of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options for patients....